WHO Pilots Pre-Submission GMP Inspections To Facilitate Prequalification Of Medicines
Executive Summary
The WHO pilot will allow drug makers seeking prequalification for their medicinal products to work simultaneously on addressing GMP issues and preparing their dossiers for submission.
You may also be interested in...
New WHO Prequalification Fees To Reap $20m A Year; Prices Could Rise As A Result
A new financing arrangement due to take effect in January 2017 will see manufacturers paying fees for the World Health Organization’s prequalification program in an effort to give it a firmer footing in the long term. While manufacturers have welcomed the new fee structure, the NGO Health Action International says safeguards will be needed to ensure regulation remains robust.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.